It is recommended for the control of signs associated with non infectious degenerative and or traumatic arthritis of canine synovial joints.
Adequan dosing chart for dogs.
Possible adverse reactions were reported after 2 1 of the.
The safe use of adequan canine used in breeding pregnant or lactating dogs has not been evaluated.
At the recommended therapeutic dose and at double the recommended dose adequan canine has an excellent safety profile and injections are tolerated well.
Important safety information adequan canine should not be used in dogs who are hypersensitive to psgag or who have a known or suspected bleeding disorder.
At early signs of degenerative joint disease veterinarians can administer adequan i m.
At the approved dose 500 mg to achieve improvement shown in studies.
Administer twice weekly for up to 4 weeks maximum of 8 injections at approved dosage of 2 mg lb body weight 0 02 ml lb or 1 ml 50 lb by intramuscular im injection only.
For dogs the dose is 1 mg to 2 5 mg per pound 2 to 5 mg kg in the muscle every 3 to 5 days for up to four weeks.
It is a useful medication post surgery and is fast acting.
This dose of adequan canine should be injected intramuscularly twice a week for 4 weeks.
Adverse reactions in clinical studies transient pain at injection site transient diarrhea and abnormal bleeding were mild and self limiting.
Veterinarians may repeat the 1 4 7 series as needed upon recurrence of the clinical signs of djd.
Out of 123 dogs evaluated in clinical trials in canada and the united states only six dogs 5 experienced undesirable effects that might have been drug related.
Adequan canine is the only fda approved injectable disease modifying osteoarthritis drug dmoad for dogs.
Dosing information of polysulfated glycosaminoglycan for dogs and cats.
2 do not exceed the recommended dose or therapeutic regimen.
Medication should never be administered without first consulting your veterinarian.
The recommended dosage is 2mg per pound of the dog s weight.
In the clinical efficacy trial 24 dogs were treated with adequan canine twice weekly for 4 weeks.
Do not exceed the recommended dose or therapeutic regimen.
Dosage of adequan canine.
Use adequan canine early at the first clinical signs of oa before it progresses and cartilage is irreversibly damaged.
1 2 after the initial series veterinarians and owners alike should keep monitoring the horse s joint health and mobility.
The drug works by inhibiting one of the enzymes responsible for breaking down.
The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections.
Although improvement is generally observed after the second injection cartilage erosion ceases after the.
It has to be administered in a series of 8 injections.
It should be used with caution in dogs with renal or hepatic impairment.
